ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Bone Research
This article is part of the Research TopicEmerging Therapies for Metabolic Bone DiseasesView all articles
Gut microbiota dysbiosis affects the local renin-angiotensin system to induce osteoporosis
Provisionally accepted- The Affiliated Hospital of Southwest Medical University, Luzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction The gut microbiota has been found to play a key role in bone metabolism, and renin-angiotensin components are locally expressed in bones and affect bone metabolism, but the link between the two is still unclear. This study aims to investigate whether gut microbiota dysbiosis causes osteoporosis through local renin-angiotensin system (RAS) Methods Osteoporosis was induced in mice by long-term antibiotic feeding, which disrupted their gut microbiota. Subsequently, the role of RAS in this process was investigated by modulating angiotensin II receptor activity. Results Long-term antibiotic treatment leads to significant alterations in gut microbiota and leads to osteoporosis, and that localized RAS in bone tissue promotes osteoclast proliferation and activity through up-regulation of ERK1/2 to promote RANKL release and inflammatory infiltration, leading to osteoporosis, and that the angiotensin II Type 2 Receptor (AT2R) may be an important target for this process. Conclusions Dysbiosis of the gut microbiota leads to osteoporosis by enhancing the activity of the local renin-angiotensin system in bones. Upregulation of ERK1/2 and RANKL, along with inflammatory responses, collectively drive bone loss. AT2R may be a potential therapeutic target. These findings highlight the role of the gut-bone axis and suggest that targeted therapeutic approaches should be further investigated.
Keywords: Gut Microbiota, Osteoporosis, Renin-Angiotensin System, RANKL, AT2R
Received: 04 Sep 2025; Accepted: 27 Nov 2025.
Copyright: © 2025 Zhong, Wang, Han, Huang, Xie, Yu, Liu, Hu, Tan and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
MeiYun Tan
Xing Guo
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
